Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment
Main Authors: | Nicholas Winters, Mireille E. Schnitzer, Jonathon R. Campbell, Susannah Ripley, Carla Winston, Rada Savic, Nafees Ahmad, Gregory Bisson, Keertan Dheda, Ali Esmail, Medea Gegia, Ignacio Monedero, Margareth Pretti Dalcolmo, Denise Rodrigues, Rupak Singla, Jae-Joon Yim, Dick Menzies |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553332/?tool=EBI |
Similar Items
-
Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.
by: Nicholas Winters, et al.
Published: (2023-01-01) -
Tuberculose e TBMR: mecanismos imunológicos e novas ferramentas de controle da doença
by: Roberta Olmo Pinheiro, et al.
Published: (2008-01-01) -
Tuberculose e coronavírus: o que sabemos?
by: Ethel Leonor Noia Maciel, et al.
Published: (2020-04-01) -
Editorial
by: Carlos Alberto de Castro Pereira, et al.
Published: (2004-06-01) -
Tuberculose multirresistente no Brasil: histórico e medidas de controle Multiresistant tuberculosis in Brazil: history and control
by: Margareth Pretti Dalcolmo, et al.
Published: (2007-09-01)